These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 2780252
21. Pharmacological properties of ATP-sensitive K+ channels in mammalian skeletal muscle cells. Allard B, Lazdunski M. Eur J Pharmacol; 1993 Jun 04; 236(3):419-26. PubMed ID: 8359200 [Abstract] [Full Text] [Related]
22. Comparison of the effects of putative activators of K+ channels on pancreatic B-cell function. Plant TD, Garrino MG, Henquin JC. Pflugers Arch; 1989 Jun 04; 414 Suppl 1():S152-3. PubMed ID: 2528721 [No Abstract] [Full Text] [Related]
23. Mechanical, biochemical and electrophysiological studies of RP 49356 and cromakalim in guinea-pig and bovine trachealis muscle. Berry JL, Elliott KR, Foster RW, Green KA, Murray MA, Small RC. Pulm Pharmacol; 1991 Jun 04; 4(2):91-8. PubMed ID: 1666532 [Abstract] [Full Text] [Related]
24. Comparative effects of the K+ channel openers, pinacidil and cromakalim on vascular tone: sensitivity to glyburide and calcium. Triggle CR, Li YQ, Wyse DG. Proc West Pharmacol Soc; 1992 Jun 04; 35():97-102. PubMed ID: 1502246 [No Abstract] [Full Text] [Related]
25. Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil. Wilson C, Coldwell MC, Howlett DR, Cooper SM, Hamilton TC. Eur J Pharmacol; 1988 Aug 02; 152(3):331-9. PubMed ID: 2851450 [Abstract] [Full Text] [Related]
26. Vascular pharmacology of ATP-sensitive K+ channels: interactions between glyburide and K+ channel openers. Meisheri KD, Khan SA, Martin JL. J Vasc Res; 1993 Aug 02; 30(1):2-12. PubMed ID: 8435468 [Abstract] [Full Text] [Related]
27. Cromakalim- and RP 49356-induced 42K+ and 86Rb+ efflux in rat myometrium. Piper IT, Hollingsworth M. Eur J Pharmacol; 1995 Sep 05; 283(1-3):1-8. PubMed ID: 7498297 [Abstract] [Full Text] [Related]
28. [Effect of potassium channel openers on hypoxic pulmonary vasoconstriction]. Matsumoto H, Nakano H, Akiba Y, Osanai S, Tobise K, Onodera S. Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug 05; 30(8):1488-95. PubMed ID: 1434222 [Abstract] [Full Text] [Related]
29. [Potential role of ATP-sensitive K+ channels in ischemia- and reperfusion-induced arrhythmias]. Nakaya H. Kokyu To Junkan; 1993 Jun 05; 41(6):512-20. PubMed ID: 8337509 [No Abstract] [Full Text] [Related]
30. [Advance in pharmacology of potassium channels in cardiovascular system and their clinical use]. Wu Y, Fang D. Zhonghua Yi Xue Za Zhi; 1992 Mar 05; 72(3):180-3. PubMed ID: 1319810 [No Abstract] [Full Text] [Related]
31. Potassium channel activator drugs: mechanism of action, pharmacological properties, and therapeutic potential. Longman SD, Hamilton TC. Med Res Rev; 1992 Mar 05; 12(2):73-148. PubMed ID: 1535674 [No Abstract] [Full Text] [Related]
32. Hypoglycemic sulfonylureas antagonize the effects of cromakalim and pinacidil on 86Rb fluxes and contractile activity in the rat aorta. Lebrun P, Fang ZY, Antoine MH, Herchuelz A, Hermann M, Berkenboom G, Fontaine J. Pharmacology; 1990 Mar 05; 41(1):36-48. PubMed ID: 2122482 [Abstract] [Full Text] [Related]
33. Modulation of intracellular calcium by potassium channel openers in vascular muscle. Erne P, Hermsmeyer K. Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec 05; 344(6):706-15. PubMed ID: 1775202 [Abstract] [Full Text] [Related]
34. Guinea-pig isolated trachealis: the effects of charybdotoxin on mechanical activity, membrane potential changes and the activity of plasmalemmal K(+)-channels. Murray MA, Berry JL, Cook SJ, Foster RW, Green KA, Small RC. Br J Pharmacol; 1991 Jul 05; 103(3):1814-8. PubMed ID: 1718525 [Abstract] [Full Text] [Related]
35. Analysis of cromakalim-, pinacidil-, and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery. Ksoll E, Parsons AA, Mackert JR, Schilling L, Wahl M. Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr 05; 343(4):377-83. PubMed ID: 1830131 [Abstract] [Full Text] [Related]
36. Characteristics of KRN2391, a novel vasodilator, compared with those of cromakalim, pinacidil and nifedipine in rat aorta. Kashiwabara T, Nakajima S, Izawa T, Fukushima H, Nishikori K. Eur J Pharmacol; 1991 Apr 10; 196(1):1-7. PubMed ID: 1678711 [Abstract] [Full Text] [Related]
37. Cromakalim and pinacidil dilate small mesenteric arteries but not small cerebral arteries. McCarron JG, Quayle JM, Halpern W, Nelson MT. Am J Physiol; 1991 Aug 10; 261(2 Pt 2):H287-91. PubMed ID: 1908639 [Abstract] [Full Text] [Related]
38. K(+)-channel openers for relaxation of isolated penile erectile tissue from rabbit. Holmquist F, Andersson KE, Fovaeus M, Hedlund H. J Urol; 1990 Jul 10; 144(1):146-51. PubMed ID: 2359166 [Abstract] [Full Text] [Related]
39. Comparative effects of the potassium channel openers cromakalim and pinacidil and the cromakalim analog U-89232 on isolated vascular and cardiac tissue. Norman NR, Toombs CF, Khan SA, Buchanan LV, Cimini MG, Gibson JK, Meisheri KD, Shebuski RJ. Pharmacology; 1994 Aug 10; 49(2):86-95. PubMed ID: 7972325 [Abstract] [Full Text] [Related]
40. Effects of ATP-sensitive K+ channel openers on pacemaker activity in isolated single rabbit sino-atrial node cells. Satoh H. J Cardiovasc Pharmacol; 1993 Dec 10; 22(6):863-8. PubMed ID: 7509906 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]